[{"from": "human", "value": "Provide a description of this molecule. [C][N][C][C][C@@H1][Branch1][Branch2][C@@H1][Branch1][Ring2][C][Ring1][=Branch1][O][C][=C][Branch2][Ring1][=N][C][=C][Branch2][Ring1][#Branch1][C][=C][Ring1][=Branch1][O][C][=Branch1][=Branch1][=C][C][Ring1][=Branch1][=O][C][=C][C][=C][C][=C][Ring1][=Branch1][Cl][O][O]"}, {"from": "gpt", "value": "The molecule is a synthetic dihydroxyflavone that is 5,7-dihydroxyflavone which is substituted by a 3-hydroxy-1-methylpiperidin-4-yl group at position 8 and by a chlorine at the 2' position (the (-)-3S,4R stereoisomer). A cyclin-dependent kinase 9 (CDK9) inhibitor, it has been studied for the treatment of acute myeloid leukaemia, arthritis and atherosclerotic plaque formation. It has a role as an antineoplastic agent, an EC 2.7.11.22 (cyclin-dependent kinase) inhibitor, an antirheumatic drug and an apoptosis inducer. It is a dihydroxyflavone, a hydroxypiperidine, a member of monochlorobenzenes and a tertiary amino compound. It is a conjugate base of an alvocidib(1+)."}]